Imagine going through a painful medical procedure and finding relief without needing strong painkillers. For cancer patients undergoing a procedure called percutaneous transhepatic biliary drainage, a new study explored the use of virtual reality combined with guided breathing techniques to help manage pain. This procedure can be quite uncomfortable, and traditional pain management often relies on opioids, which come with risks of addiction and side effects. In the study, patients who used virtual reality with breathing guidance consumed much less opioid medication the day after the procedure compared to those who used standard virtual reality. While both groups reported similar satisfaction with their experience, the significant reduction in opioid use suggests that this innovative approach could help patients feel better and rely less on medications. However, it's important to note that this was a small study, and more research is needed to confirm these findings and understand how best to implement this method in clinical settings. Still, the potential for virtual reality and breathing techniques to enhance pain management offers hope for a safer and more comfortable experience for patients.
Can Virtual Reality and Breathing Techniques Reduce Cancer Pain?
Plain Language Summary
What this means for you:
Virtual reality with guided breathing could help cancer patients manage pain with less reliance on opioids. What this means for you:
Virtual reality with guided breathing could help cancer patients manage pain with less reliance on opioids. View Original Abstract ↓
PURPOSE: This study aimed to evaluate the feasibility and analgesic potential of a guided breathing virtual reality (VR) intervention for managing pain in patients with cancer undergoing percutaneous transhepatic biliary drainage (PTBD).
METHODS: In a randomized, controlled design, patients were assigned to receive either VR with guided deep breathing (VRBG) or conventional VR without breath guidance (VROG). Each group experienced two 7-min VR sessions featuring calming visuals and narration, with the VRBG receiving additional prompts to induce slow, rhythmic breathing.
RESULTS: A total of 45 patients (VRBG, 22; VROG, 23) were enrolled. On the day following PTBD, opioid consumption was significantly lower with VRBG than with VROG (20.25 vs. 56.61 morphine milligram equivalents; P = 0.044). No significant difference was observed in opioid use on the day of the procedure. Patient satisfaction and willingness to reuse VR were comparable between the groups. Mild adverse events were infrequent and self-limiting.
CONCLUSION: The study findings suggest that incorporating structured breathing guidance into VR may enhance its analgesic effect and reduce reliance on opioids after invasive procedures. To our knowledge, this is the first prospective trial to combine VR and guided breathing for PTBD-related pain, and our findings support the potential of guided breathing VR as a non-pharmacological adjunct in cancer pain management. Trial Registration Clinical Research Information Service ( http://cris.nih.go.kr , KCT0006775).